2 Result: AVROBIO
Ault Alliance Soars On Financial Status; AVROBIO Climbs On Strategic Leap
July 12th, 2023
Shares of Ault Alliance, Inc. (NYSE American: AULT) surged over 100% in pre-market trading after the company provided a business update highlighting its financial status. With approximately 2.1 million shares outstanding and a book value of around. Read more
AVROBIO Sells Cystinosis Therapy Program to Novartis, Stock Surges; Compass Minerals Inks Lithium Supply Deal with Ford; Global-e Online Beats Estimates, Stock Declines
May 22nd, 2023
AVROBIO, Inc. (Nasdaq: AVRO) has made a significant announcement, revealing that it has entered into an agreement to sell its investigational hematopoietic stem cell (HSC) gene therapy program for the treatment of cystinosis to Novartis (NYSE: NVS). . Read more
Load More Content
Want To Find Some News?
News By Industries
Recent Post
-
Countdown to Earnings: Nutanix, CrowdStrike, and Synopsys on Deck
August 23rd, 2026Investors Eye Semtech, Intuit, and nCino as Earnings Loom
August 22nd, 2026FTC Files Amicus Brief to Protect Competition in Biologic Drug Markets
August 21st, 2026
Member Login